ClearBridge Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $111M | Sell |
509,075
-381,050
| -43% | -$84.5M | 0.1% | 192 |
|
|
2025
Q4 | $203M | Sell |
890,125
-204,014
| -19% | -$46.5M | 0.16% | 133 |
|
|
2025
Q3 | $253M | Sell |
1,094,139
-631,891
| -37% | -$129M | 0.19% | 117 |
|
|
2025
Q2 | $320M | Sell |
1,726,030
-241,132
| -12% | -$44.8M | 0.26% | 94 |
|
|
2025
Q1 | $412M | Sell |
1,967,162
-623,690
| -24% | -$121M | 0.36% | 79 |
|
|
2024
Q4 | $460M | Sell |
2,590,852
-252,152
| -9% | -$46.4M | 0.37% | 72 |
|
|
2024
Q3 | $561M | Sell |
2,843,004
-1,004,660
| -26% | -$188M | 0.44% | 65 |
|
|
2024
Q2 | $660M | Sell |
3,847,664
-307,104
| -7% | -$50.9M | 0.54% | 50 |
|
|
2024
Q1 | $757M | Buy |
4,154,768
+212,149
| +5% | +$36.6M | 0.6% | 40 |
|
|
2023
Q4 | $611M | Buy |
3,942,619
+217,817
| +6% | +$31.8M | 0.53% | 51 |
|
|
2023
Q3 | $555M | Buy |
3,724,802
+208,675
| +6% | +$30.6M | 0.53% | 49 |
|
|
2023
Q2 | $474M | Buy |
3,516,127
+134,425
| +4% | +$19.7M | 0.43% | 64 |
|
|
2023
Q1 | $539M | Buy |
3,381,702
+72,938
| +2% | +$11.2M | 0.52% | 51 |
|
|
2022
Q4 | $535M | Sell |
3,308,764
-117,859
| -3% | -$18.1M | 0.53% | 51 |
|
|
2022
Q3 | $460M | Buy |
3,426,623
+81,670
| +2% | +$11.7M | 0.46% | 62 |
|
|
2022
Q2 | $512M | Sell |
3,344,953
-126,973
| -4% | -$19.4M | 0.48% | 54 |
|
|
2022
Q1 | $563M | Sell |
3,471,926
-348,470
| -9% | -$50.6M | 0.42% | 65 |
|
|
2021
Q4 | $517M | Sell |
3,820,396
-36,597
| -0.9% | -$4.32M | 0.35% | 76 |
|
|
2021
Q3 | $416M | Sell |
3,856,993
-197,991
| -5% | -$22.6M | 0.3% | 86 |
|
|
2021
Q2 | $457M | Sell |
4,054,984
-106,236
| -3% | -$12M | 0.32% | 82 |
|
|
2021
Q1 | $450M | Sell |
4,161,220
-94,967
| -2% | -$10.2M | 0.34% | 78 |
|
|
2020
Q4 | $456M | Sell |
4,256,187
-136,839
| -3% | -$13.1M | 0.35% | 72 |
|
|
2020
Q3 | $385M | Buy |
4,393,026
+118,936
| +3% | +$11.2M | 0.33% | 77 |
|
|
2020
Q2 | $420M | Buy |
4,274,090
+3,483,416
| +441% | +$307M | 0.38% | 72 |
|
|
2020
Q1 | $60.2M | Buy |
790,674
+200,714
| +34% | +$17.1M | 0.07% | 223 |
|
|
2019
Q4 | $52.8M | Buy |
589,960
+577,835
| +4,766% | +$48M | 0.04% | 314 |
|
|
2019
Q3 | $918K | Buy |
12,125
+185
| +2% | +$12.7K | ﹤0.01% | 666 |
|
|
2019
Q2 | $868K | Buy |
11,940
+466
| +4% | +$36.6K | ﹤0.01% | 671 |
|
|
2019
Q1 | $925K | Sell |
11,474
-1,500
| -12% | -$123K | ﹤0.01% | 681 |
|
|
2018
Q4 | $1.2M | Buy |
12,974
+1,000
| +8% | +$87.9K | ﹤0.01% | 684 |
|
|
2018
Q3 | $1.13M | Sell |
11,974
-1,800
| -13% | -$171K | ﹤0.01% | 714 |
|
|
2018
Q2 | $1.28M | Sell |
13,774
-8
| -0.1% | -$781 | ﹤0.01% | 631 |
|
|
2018
Q1 | $1.3M | Buy |
13,782
+947
| +7% | +$104K | ﹤0.01% | 619 |
|
|
2017
Q4 | $1.24M | Buy |
12,835
+4,412
| +52% | +$416K | ﹤0.01% | 624 |
|
|
2017
Q3 | $748K | Sell |
8,423
-324
| -4% | -$24.7K | ﹤0.01% | 655 |
|
|
2017
Q2 | $634K | Buy |
8,747
+450
| +5% | +$30.3K | ﹤0.01% | 668 |
|
|
2017
Q1 | $541K | Sell |
8,297
-1,628
| -16% | -$102K | ﹤0.01% | 713 |
|
|
2016
Q4 | $622K | Sell |
9,925
-534,763
| -98% | -$32.6M | ﹤0.01% | 711 |
|
|
2016
Q3 | $34.4M | Sell |
544,688
-59,811
| -10% | -$3.87M | 0.04% | 341 |
|
|
2016
Q2 | $37.4M | Sell |
604,499
-9,901
| -2% | -$603K | 0.04% | 312 |
|
|
2016
Q1 | $35.1M | Sell |
614,400
-4,611
| -0.7% | -$257K | 0.04% | 320 |
|
|
2015
Q4 | $36.7M | Sell |
619,011
-435,591
| -41% | -$25.1M | 0.04% | 322 |
|
|
2015
Q3 | $57.4M | Sell |
1,054,602
-121,543
| -10% | -$7.91M | 0.07% | 241 |
|
|
2015
Q2 | $79M | Sell |
1,176,145
-6,905
| -0.6% | -$451K | 0.08% | 217 |
|
|
2015
Q1 | $69.3M | Sell |
1,183,050
-3,583
| -0.3% | -$216K | 0.07% | 240 |
|
|
2014
Q4 | $77.7M | Buy |
1,186,633
+121,957
| +11% | +$7.69M | 0.08% | 219 |
|
|
2014
Q3 | $61.5M | Buy |
1,064,676
+72,932
| +7% | +$4.05M | 0.07% | 258 |
|
|
2014
Q2 | $56M | Sell |
991,744
-2,655
| -0.3% | -$139K | 0.06% | 271 |
|
|
2014
Q1 | $51.1M | Sell |
994,399
-140
| -0% | -$7.08K | 0.06% | 275 |
|
|
2013
Q4 | $52.5M | Buy |
994,539
+29,792
| +3% | +$1.46M | 0.07% | 268 |
|
|
2013
Q3 | $43.2M | Sell |
964,747
-2,115
| -0.2% | -$93.8K | 0.06% | 281 |
|
|
2013
Q2 | $40M | Buy |
+966,862
| New | +$42.3M | 0.06% | 264 |
|
Other funds holding ABBV
VCM
VPM
ClearBridge Investments's ABBV Position: Q1 2026 in Review
ClearBridge Investments reduced its AbbVie (ABBV) stake by 43% in Q1 2026, selling an estimated $84.5M and leaving 509,075 shares worth $111M. The position accounts for 0.1% of the portfolio, ranked #192.
ClearBridge Investments first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $757M in Q1 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- ClearBridge Investments held 509,075 shares of AbbVie worth $111M as of Q1 2026.
- ClearBridge Investments sold 381,050 AbbVie shares in Q1 2026, an estimated $84.5M.
- AbbVie made up 0.1% of ClearBridge Investments's portfolio in Q1 2026, its #192 holding.
- ClearBridge Investments first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- ClearBridge Investments's AbbVie position peaked at $757M in Q1 2024.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on ClearBridge Investments's 13F filing for Q1 2026, filed 13 May 2026.